Skip to content

Predictive Value of Nutritional and Inflammatory Indices for Postoperative Complications After Bariatric Surgery

The Predictive Value of Nutritional and Inflammatory Indices for Postoperative Complications in Bariatric Surgery Patients: A Single-Centre Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07747168
Acronym
BARI-NUTRI
Enrollment
600
Registered
2026-08-05
Start date
2023-01-01
Completion date
2027-12-30
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity, Obesity (BMI > 35)

Keywords

Bariatric Surgery, Sleeve Gastrectomy, Gastric Bypass, Prognostic Nutritional Index, PNI, Neutrophil-to-Lymphocyte Ratio, NLR, Platelet-to-Lymphocyte Ratio, PLR, Systemic Immune-Inflammation Index, SII, Systemic Inflammation Response Index, Clavien-Dindo Classification, Risk Stratification, C-Reactive Protein-to-Albumin Ratio, CAR

Brief summary

Bariatric surgery is an effective treatment for severe obesity, but postoperative complications remain an important cause of morbidity. Several nutritional and inflammatory biomarkers derived from routine preoperative blood tests have been proposed as predictors of postoperative outcomes; however, their comparative value in bariatric surgery has not been fully established. This single-center retrospective cohort study will evaluate the ability of preoperative nutritional and inflammatory indices, including the Prognostic Nutritional Index (PNI), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and C-reactive Protein-to-Albumin Ratio (CAR), to predict 30-day postoperative complications following bariatric surgery. The study aims to identify the most clinically useful biomarker for preoperative risk stratification and optimization of perioperative care.

Detailed description

Bariatric surgery is the most effective treatment for severe obesity and obesity-related comorbidities. Despite advances in perioperative care, early postoperative complications continue to contribute to patient morbidity and healthcare utilization. Reliable preoperative risk stratification tools are therefore essential for identifying patients at increased risk and optimizing perioperative management. Nutritional status and systemic inflammation have emerged as important determinants of surgical outcomes. Several composite indices calculated from routinely available laboratory parameters, including albumin, C-reactive protein, leukocyte subsets, and platelet counts, have demonstrated prognostic value in different surgical populations. However, evidence regarding their comparative predictive performance in bariatric surgery remains limited. This single-center retrospective cohort study will include consecutive adult patients who underwent sleeve gastrectomy or gastric bypass procedures between 2023 and 2026. Preoperative nutritional and inflammatory indices (PNI, NLR, PLR, SII, SIRI, and CAR) will be calculated from the most recent preoperative laboratory values. The primary outcome is the occurrence of any Clavien-Dindo grade II or higher postoperative complication within 30 days after surgery. Secondary outcomes include the Comprehensive Complication Index (CCI), length of hospital stay, intensive care unit admission, and 30-day mortality. Multivariable regression analyses will be performed to determine the independent predictive value of each index after adjustment for relevant demographic and clinical variables. The findings of this study are expected to improve preoperative risk assessment and facilitate identification of patients who may benefit from targeted perioperative optimization strategies.

Interventions

PROCEDUREBariatric Surgery

Standard bariatric surgical procedures performed as part of routine clinical care, including sleeve gastrectomy and gastric bypass procedures (Roux-en-Y gastric bypass, SADI, and SASI). No study-specific intervention was assigned.

Sponsors

G.Gennimatas General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults aged 18 years or older. * Patients who underwent bariatric surgery (sleeve gastrectomy, Roux-en-Y gastric bypass, SADI, or SASI). * Availability of complete preoperative laboratory data required for calculation of nutritional and inflammatory indices. * Availability of postoperative follow-up data for assessment of 30-day complications.

Exclusion criteria

* Patients younger than 18 years. * Missing key preoperative laboratory values required to calculate study indices. * Incomplete medical records or unavailable 30-day postoperative outcome data.

Design outcomes

Primary

MeasureTime frameDescription
30-Day Postoperative Complications (Clavien-Dindo Grade II or Higher)30 days after surgeryOccurrence of any postoperative complication classified as Clavien-Dindo grade II or higher within 30 days after bariatric surgery.

Secondary

MeasureTime frameDescription
Comprehensive Complication Index (CCI)30 days after surgeryComprehensive Complication Index calculated from all postoperative complications occurring within 30 days after surgery.
Length of Hospital StayFrom surgery until hospital discharge (up to 30 days)Total duration of hospitalization following bariatric surgery.
From surgery until hospital discharge (up to 30 days)30 days after surgeryAll-cause mortality occurring within 30 days after bariatric surgery.

Countries

Greece

Contacts

PRINCIPAL_INVESTIGATORAmalia Douma, MD PHD

G.Gennimatas General Hospital

PRINCIPAL_INVESTIGATORPanagiotis Chatzistavridis, MD

G.Gennimatas General Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026